Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.
- DOI
- 10.3389/fmed.2022.821871
- Published
- 2022
- Container
- Frontiers in medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2022.821871,
title = {Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.},
author = {Ghazal S and Ridha Z and D'Aguanno K and Nassim D and Quaiattini A and Netchiporouk E and Poulin Y and Kalia S and Marcoux D and Piguet V and Jack C},
year = {2022},
journal = {Frontiers in medicine},
doi = {10.3389/fmed.2022.821871},
url = {https://doi.org/10.3389/fmed.2022.821871}
}RIS
TY - JOUR TI - Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II. AU - Ghazal S AU - Ridha Z AU - D'Aguanno K AU - Nassim D AU - Quaiattini A AU - Netchiporouk E AU - Poulin Y AU - Kalia S AU - Marcoux D AU - Piguet V AU - Jack C PY - 2022 JO - Frontiers in medicine DO - 10.3389/fmed.2022.821871 UR - https://doi.org/10.3389/fmed.2022.821871 ER -
APA
S, G., Z, R., K, D., D, N., A, Q., E, N., Y, P., S, K., D, M., V, P., & C, J. (2022). Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.. Frontiers in medicine. https://doi.org/10.3389/fmed.2022.821871
Source records
- pubmed · retrieved 2026-09-27T08:49:43.941Z